Houston Medical Robotics Inc.

Aiming to standardize and automate central venous access

More than five million central venous catheter lines are placed in the US each year, but the high-volume, invasive procedure has a troubling 2% to 26% procedural error rate, and can cause serious and expensive complications. Houston Medical Robotics Inc. has developed the Euclid Tier 1 Mini Access image-guided medical robotics vascular access platform to standardize, automate, and increase the safety of this critical procedure.

[Houston Medical Robotics Inc.]

17225 El Camino Real

More from Archive

More from Medtech Insight